STOCK TITAN

Olema (NASDAQ: OLMA) director granted 27,061 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Olema Pharmaceuticals director Raman Prakash received two stock option grants as equity compensation. The awards cover a combined 27,061 shares of common stock at an exercise price of $14.59 per share, expiring on April 27, 2036.

Options on 24,150 shares vest in full on June 11, 2026, while options on 2,911 shares vest in 36 equal monthly installments starting April 28, 2026. All vesting is conditioned on Prakash’s continuous service with the company.

Positive

  • None.

Negative

  • None.
Insider Raman Prakash
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 2,911 $0.00 --
Grant/Award Stock Option (Right to Buy) 24,150 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 2,911 shares (Direct, null)
Footnotes (1)
  1. The shares subject to the option vest in full on June 11, 2026, subject to the Reporting Person's continuous service through such vesting date. The shares subject to the option vest in a series of 36 successive equal monthly installments measured from April 28, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.
Option grant size 1 24,150 options Stock Option (Right to Buy) on Common Stock
Option grant size 2 2,911 options Stock Option (Right to Buy) on Common Stock
Total options granted 27,061 options Combined derivative awards to director
Exercise price $14.59 per share Conversion or exercise price for both option grants
Expiration date April 27, 2036 Option term end date for both grants
Cliff vesting date June 11, 2026 24,150-share grant vests in full on this date
Monthly vesting schedule 36 monthly installments 2,911-share grant vests from April 28, 2026
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: 14.5900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares subject to the option vest in full on June 11, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service financial
"subject to the Reporting Person's continuous service through such vesting date"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Raman Prakash

(Last)(First)(Middle)
C/O OLEMA PHARMACEUTICALS, INC.
780 BRANNAN STREET

(Street)
SAN FRANCISCO CALIFORNIA 94103

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Olema Pharmaceuticals, Inc. [ OLMA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$14.5904/28/2026A2,911 (1)04/27/2036Common Stock2,911$02,911D
Stock Option (Right to Buy)$14.5904/28/2026A24,150 (2)04/27/2036Common Stock24,150$024,150D
Explanation of Responses:
1. The shares subject to the option vest in full on June 11, 2026, subject to the Reporting Person's continuous service through such vesting date.
2. The shares subject to the option vest in a series of 36 successive equal monthly installments measured from April 28, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.
/s/ Shawnte Mitchell, Attorney-in-Fact04/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Olema Pharmaceuticals (OLMA) director Raman Prakash receive in this Form 4 filing?

Raman Prakash received two grants of stock options as equity compensation, covering a total of 27,061 shares of Olema common stock at an exercise price of $14.59 per share, with vesting tied to his continued service with the company.

What are the key terms of Raman Prakash’s Olema (OLMA) stock option awards?

The options allow Prakash to buy 27,061 Olema common shares at $14.59 per share until April 27, 2036. One grant vests all at once on June 11, 2026, and the other vests in 36 equal monthly installments starting April 28, 2026.

How do the Olema (OLMA) stock options granted to Raman Prakash vest over time?

Options on 24,150 shares vest in full on June 11, 2026. Options on 2,911 shares vest in 36 equal monthly installments beginning April 28, 2026. Each vesting tranche requires Prakash to remain in continuous service through the applicable vesting date.

Are Raman Prakash’s Olema (OLMA) stock option grants open-market purchases or compensation?

These transactions are compensation-related stock option grants, not open-market share purchases. The options were awarded at a grant price of $0.00, carry a $14.59 exercise price, and become exercisable only as they vest based on Prakash’s continuing service.

When do the Olema (OLMA) stock options granted to director Raman Prakash expire?

Both stock option grants reported for Raman Prakash share the same expiration date of April 27, 2036. He can exercise vested options at $14.59 per share any time before expiration, subject to Olema’s equity plan and applicable service conditions.

How many Olema (OLMA) shares can be acquired under each of Raman Prakash’s option grants?

One option grant covers 24,150 underlying Olema common shares, while the second grant covers 2,911 shares. Together, the awards permit Prakash to purchase up to 27,061 shares if all vesting conditions are satisfied and the options are exercised.